Announcements

25 September 2024
Meet Us at the Chinese Chemical Society’s 11th Natural Product Synthesis—Young Investigator Forum, 18–20 October 2024, Wuhan, China


MDPI will attend the Chinese Chemical Society’s 11th Natural Product Synthesis—Young Investigator Forum, which will be held at Wuhan University, from 18 to 20 October 2024.

The conference is hosted by the Organic Chemistry Discipline Committee of the Chinese Chemical Society and co-organized by the School of Chemistry and Molecular Sciences of Wuhan University and the School of Pharmacy of Tongji Medical College of Huazhong University of Science and Technology.

This series of conferences is an academic seminar held to carry forward the fine academic traditions of the older generation of chemists, highlight the important position of natural product synthesis in research fields such as organic chemistry, medicinal chemistry and chemical biology, and also to build a good academic exchange platform for young scholars. This forum will conduct extensive and in-depth discussions on the development trends and hot issues of common concern in related fields such as natural product total synthesis, synthetic methodology, chemical biology, medicinal chemistry and pharmaceutical process research.

The following MDPI journals will be represented at the conference:

If you are planning on attending this conference, please do not hesitate to stop by our booth and start a conversation with us. Our delegates look forward to meeting you in person and answering any questions that you may have. For more information about the conference, please visit the following website: https://www.chemsoc.org.cn/meeting/NPSYIF2024/.

25 September 2024
Meet Us at the 10th German Pharm-Tox Summit, 25–28 March 2025, Hannover, Germany


The GPTS is organized by the German Society for Experimental and Clinical Pharmacology and Toxicology (DGPT) together with several other scientific societies.

The scientific committee covers all fields of pharmacology and toxicology and will ensure that the program, which consists of three plenary talks, various symposia including one by the Paul Martini Foundation, many short talk and poster sessions, will provide exciting insights into cutting-edge topics of pharmacology and toxicology and enhance scientific exchange to initiate new collaborations. The organizers strive to further develop the conference with high academic standards and ample opportunities for scientific exchange and are particularly interested in providing scientific opportunities for junior scientists.

The 10th German Pharm-Tox Summit will be held in Hannover, Germany, from 25–28 March 2025.

For more information please visit: https://gpts-kongress.de/.

11 September 2024
MDPI’s 2023 Best PhD Thesis Awards—Winners Announced


MDPI’s Best PhD Thesis Awards are granted to promising young scholars whose PhD theses are deemed exceptional within their respective research fields. These awards aim to encourage young scholars to continue their outstanding accomplishments and further contribute to their field.

We extend our heartfelt congratulations to the 54 winners of the 2023 Best PhD Thesis Awards and wish them success with their future research endeavors.

MDPI will continue to provide support and recognition to the academic community. To learn more about all the awardees and their research projects in your field of study, please visit the following pages:

About MDPI Awards:

To reward the academic community, especially young researchers, and enhance communication among scientists, MDPI journals regularly offer various awards to researchers in specific fields. These awards, serving as a source of inspiration and recognition, help raise the influence of talented individuals who have been credited with outstanding achievements and are making a significant contribution to the advancement of their fields.

To explore more MDPI awards, please click here.

3 September 2024
MDPI INSIGHTS: The CEO's Letter #15 - CHORUS, Best Paper Award, August Events

Welcome to the MDPI Insights: The CEO's Letter.

In these monthly letters, I will showcase two key aspects of our work at MDPI: our commitment to empowering researchers and our determination to facilitating open scientific exchange.


Opening Thoughts

I am pleased to share that MDPI is now an Affiliate Member of CHORUS, a not-for-profit organization dedicated to ensuring public access to articles reporting on U.S. government-funded research. This partnership highlights our long-standing commitment to advancing Open Access (OA) publishing and meeting funders’ open research requirements.

Read the full announcement here.

With the White House Office of Science and Technology Policy (OSTP) 2022 memorandum calling for immediate public access to all federally funded research by 2026, this partnership positions MDPI to further support academic institutions in adhering to national mandates while providing authors with fully compliant (CC-BY) OA journals.

The CHORUS platform went live in July 2014 and includes NASA, the U.S. Department of Energy, the U.S. Department of Defense, the U.S. Geological Survey, and the National Science Foundation.

“This partnership positions MDPI to further support academic institutions in adhering to national mandates”

Joining CHORUS perfectly aligns our mission as the leading OA publisher, which is to drive transparency and innovation in scholarly publishing, with that of CHORUS itself, which is to advance Open Access research. It will also support MDPI publications from organizations such as NASA, with 1,200 research papers published by NASA-affiliated authors as at 31 August 2024.

Impactful Research

MDPI’s Best Paper Awards—Award-Winning Papers in 2023 Announced

MDPI is committed to supporting and recognizing the academic community and is proud to announce the recipients of the 2023 Best Paper Awards, which recognize high-quality papers of significant scientific merit and impact. Each year, the editors of our journals carefully select papers that showcase outstanding scientific achievement.

This year, 115 Best Paper Awards were presented, chosen from 346 exceptional papers in a highly competitive selection process. Congratulations to the authors for their remarkable contributions!

To learn more about all the awardees and their research projects, visit the following pages:

About MDPI Awards
MDPI regularly offers various awards to recognize researchers, particularly young scientists, and to promote communication within the scientific community. These awards exist to inspire and acknowledge talented scientists who have made significant contributions to advancing their fields.

To find out more MDPI awards, please click here.

“Our awards exist to inspire and acknowledge talented scientists”

Inside MDPI

MDPI AI Team Presented at EuroSciPy 2024 in Poland

As part of the CEO Letter, I hold dear this ‘Inside MDPI’ section, where I have an opportunity to highlight various projects, teams and updates within our organization. As such, I’m happy to showcase the following presentations from members of MDPI’s Artificial Intelligence (AI) team, which were recently presented at the EuroSciPy 2024 (16th European Conference on Python in Science). This conference took place in Szczecin, Poland from 26–30 August.

“This event was a great opportunity to reinforce our commitment to innovation and excellence in publishing”

MDPI colleagues Frank Sauerburger (AI Tech Leader) and Daniele Raimondi (Senior Data Scientist) both presented at the conference. Frank discussed MDPI’s AI infrastructure, while Daniele showcased a new methodological approach we have been developing to track the journey of rejected academic manuscripts. This approach combines AI, data science and analytics to improve the identification of manuscripts and authors, enhancing our understanding of publishing dynamics.

This event was a great opportunity to reinforce our commitment to innovation and excellence in publishing. It also allowed us to contribute to the academic discussion on integrating AI and data science into scholarly communication.

From data analysis in Jupyter Notebooks to production applications: AI infrastructure at reasonable scale – Frank Sauerburger

Frank’s presentation on MDPI’s AI infrastructure provided a chance to showcase the advanced technological frameworks that power our operations. Given the technical and academic focus of EuroSciPy, this talk demonstrated how MDPI’s AI capabilities are not only cutting-edge but also central to driving efficiency and innovation in scholarly publishing. Engaging with the EuroSciPy community helps position MDPI as a leader in applying AI within the publishing industry, fostering potential collaborations and attracting interest from top researchers.

A Qdrant and Specter2 framework for tracking resubmissions of rejected manuscripts in academia – Daniele Raimondi

Daniele’s talk on the novel methodological approach that combines AI, Data Science, and Analytics was crucial in highlighting how MDPI is advancing the precision and effectiveness of manuscript and author identification. This approach is pivotal in enhancing our understanding of publishing dynamics and ensuring the quality and integrity of the academic content we manage. By presenting at EuroSciPy, we had the opportunity to engage with an audience deeply involved in scientific computing, gaining feedback and insights that could further refine our methodologies.

Thank you, Frank and Daniele, for representing MDPI so well!

I will share more about MDPI’s AI team and projects in upcoming CEO Letters, as we have a well-rounded AI and Data Team working on an exciting suite of AI products for MDPI and the scholarly community at large.

Coming Together for Science

The 1st International Conference on AI Sensors & The 10th International Symposium on Sensor Science

I am pleased to share the success of our MDPI conference The 1st International Conference on Artificial Intelligence (AI) Sensors and the 10th International Symposium on Sensor Science in Singapore this past 1–4 August.

With nearly 400 attendees, the event brought together researchers and industry experts from China, Singapore, Japan, Korea, Taiwan, India and other countries to share their findings on the latest developments in sensors, sensing technology, artificial intelligence for sensing applications and AI-enhanced sensing systems.

We accepted a total of 355 abstracts, featuring 772 authors from 28 countries. Over the course of the four-day event, 66 posters were displayed and 296 talks were delivered, including 4 plenary talks, 46 keynote speeches, 122 invited talks, and 124 selected oral presentations. View the event gallery here.

I am pleased to announce the winners of the four awards, including Best Presentation and Best Poster, recognizing the contributions of our participants during the conference.

Looking ahead, the 2nd International Conference on AI Sensors and Transducers is scheduled to take place from 29 July to 5 August, 2025, in Bangkok, Thailand.

Thank you to our Conference team, including Ionut Spatar, Teodora Nicoleta Cremene, Ang Kai Lin, Benjamin Tay, Leong Jin Yue Esther, Wong Jolin, Judith Wu, Alethea Liu and Flora Li, who were involved in making this event a success. A big thank-you also goes to our local MDPI colleagues for their support: Yu Nwe Soe, Hen Chu Yang, Kwah Zhi En Watcharapong, Zephan Yang, Daphne Neo, Huimin Cheng, Nathan Li and Ting Yin.

Upcoming In-Person Event

25–27 September, 2024
The 5th International Conference on Materials: Advances in Material Innovation
Location: Basel, Switzerland

ICM 2024 will unite experts to share insights on recent advancements in Materials Characterization, Processing and Manufacturing.

7–9 October, 2024
Non-coding RNA World 2024: Exploring Mechanisms, Designing Medicines
Location: Basel, Switzerland

ncRNA 2024 will explore the latest advances in the field, covering topics from basic biology to medical and technological applications.

Find more upcoming MDPI events here.

Closing Thoughts

The 2nd Sustainable Publishing Forum

In 2022, the International Association of Scientific, Technical and Medical Publishers (STM) outlined three goals to reflect the academic community’s shared aspirations: promoting Open Science, maintaining research integrity and fulfilling social responsibility. Open Science has evolved from the Open Access movement of the early 2000s to become a preferred model in academic publishing. Publishers and academic journals play a crucial role in ensuring research integrity, with efforts to prevent misconduct markedly on the increase now.

As the world faces sustainability challenges, the academic publishing industry is increasingly committed to contributing the achievement of the United Nations Sustainable Development Goals (SDGs). Many publishers are implementing strategies to support these objectives, including ours, which you can view here.

The 2nd MDPI Sustainable Publishing Forum provided a platform for global editors and publishers to discuss these themes, aiming to strengthen collaboration and advance the contributions that scientific publishing can make to academia and society.

“Open Science has evolved to become a preferred model in academic publishing”

The 2nd Sustainable Publishing Forum

We hosted MDPI’s 2nd Sustainable Publishing Forum in Beijing, China, on 15–16 August, attracting nearly 120 attendees from local and international publishers, university presses, scientific and technical journal associations, libraries and the Chinese Academy of Sciences. The event focused on promoting Open Science, maintaining research integrity, and fulfilling social responsibility.

This was an excellent opportunity for us to share more with conference attendees about the approach of our research integrity team. Our Head of Publishing, Peter Roth, also participated, speaking on how to identify and avoid predatory publishers and about the principles that underpin ethical academic publishing.

I extend my thanks to all of our conference speakers, including Hylke Koers (STM Solutions), who presented on STM Trends 2028 and shared insights on the STM Integrity Hub, of which MDPI is a member.

Stefan Tochev
Chief Executive Officer
MDPI AG

27 August 2024
Pharmaceuticals | Special Issue Mentor Program


We are pleased to announce the launch of a new initiative—the Pharmaceuticals Special Issue Mentor Program.

This program will enable early career researchers (who hold a Ph.D. in a related field) to experience editing a Special Issue in Pharmaceuticals (ISSN: 1424-8247) under the mentorship of our experienced Editorial Board Members or other experienced scientists. This program will be an excellent opportunity for early career scientists to gain editorial experience and cultivate their ability to edit scientific research.

The mentees’ responsibilities include the following:

  • Proposing a Special Issue title and assisting mentors in preparing a summary (around 150–200 words) and 3–10 keywords describing the background, importance, and goal of the Special Issue;
  • Writing a brief promotion plan for the Special Issue;
  • Preparing a list of scholars that may be interested in the Special Issue and personally e-mail invitations on behalf of the Guest Editors;
  • Collaborating with mentors to write an editorial for the online Special Issue.

The mentors’ responsibilities include the following:

  • Conducting a final check before the Special Issue is published online;
  • Performing editorial control of the Special Issue and quality control of the publications in a timely manner;
  • Providing suggestions to younger scholars if they have doubts or concerns regarding submissions;
  • Organizing regular video calls with young scholars and the Editorial Office to discuss problems and make suggestions to improve the Special Issue;
  • Making and submitting decisions for submissions with the assistance of mentees.

Certificates and awards:
After the Special Issue closes, the Editorial Office will provide official certificates to all the mentors and mentees.

If you are interested in this opportunity, please send your Special Issue proposal to the Pharmaceuticals Editorial Office, and we will discuss the process (i.e., mentor collaboration, Special Issue topic feasibility analysis, etc.) in further detail.

In addition to the new Special Issue mentor program, Pharmaceuticals will continue to welcome all Special Issue proposals focusing on hot research topics.

Pharmaceuticals Editorial Office

19 August 2024
MDPI’s 2023 Young Investigator Awards—Winners Announced


MDPI’s Young Investigator Awards recognize promising early career scientists, acknowledge their contributions, and foster collaboration within the scientific community. We are proud to announce the recipients for 2023, who were carefully selected by the journals’ esteemed Award Evaluation Committee.

We extend our heartfelt congratulations to the 79 winners of MDPI’s 2023 Young Investigator Awards for their excellent contributions in their research field. We look forward to seeing these rising stars continue to contribute to the advancement of science.

MDPI will continue to support and recognize the academic community. To explore details about the awardees by field, please visit the individual pages listed below:

Congratulations to all the winners for their exceptional contributions and dedication to advancing scientific research.

About MDPI Awards:
To support the academic community, particularly young researchers, and to enhance communication among scientists, MDPI journals regularly offer various awards to researchers in specific fields. These awards, serving as a source of inspiration and recognition, help to elevate the profiles of talented individuals who have made outstanding achievements and are making significant contributions to advancements in their respective fields.

To find out more about MDPI awards, please click here.

15 August 2024
Meet Us at the 11th Biennial Meeting of the Society for Free Radical Research-Asia and the Chinese National Conference of Redox Biology and Medicine 2024, 21–23 October 2024, Beijing, China


Conference: The 11th Biennial Meeting of the Society for Free Radical Research-Asia and the Chinese National Conference of Redox Biology and Medicine 2024
Organizers: Society for Redox Biology and Medicine Branch of Biophysical Society of China;
The Material Biology and Intelligent Medicine Branch of Biophysical Society of China
Date: 21–23 October 2024
Place: Beijing, China

MDPI journals will be attending the 11th Biennial Meeting of the Society for Free Radical Research-Asia and the Chinese National Conference of Redox Biology and Medicine 2024 as exhibitors. This conference will be held in Beijing, China, from 21 to 23 October 2024.

After two decades of SFRR-Asia biennial meetings, we are marching into a new era regarding the exploration of redox biology and medicine at precision, mechanistic, and in vivo levels with innovative technology and the collaboration of multiple disciplines. The coming SFRR-Asia 2024, with the theme “The new era of precision redox biology and medicine: from basic research to the intervention of aging and diseases,” will provide an opportunity to embrace research progress in the field. This conference will address a range of topics, with a particular focus on three areas of research: basic research on redox biology and medicine, redox homeostasis in aging and diseases, and precision redox intervention and health management.

The following MDPI journals will be represented:

If you will be attending this conference, our delegates look forward to meeting you in person and answering any questions that you may have. For more information about the conference, please visit the following website: https://sfrr-asia2024.tiemeeting.com.

15 August 2024
Pharmaceuticals Webinar | 20th Anniversary of Pharmaceuticals—Green Techniques for Organic and Organometallic/Coordination Synthesis and Medicinal Chemistry, 5 September 2024


Are you interested in developing pharmaceuticals in a sustainable and environmentally friendly way? If so, join us for a workshop on Green Techniques for Organic and Organometallic/Coordination Synthesis and Medicinal Chemistry! This workshop is perfect for researchers and students working in organic synthesis, medicinal chemistry, or organometallic/coordination chemistry, as well as anyone curious about greener approaches in these fields.

The workshop will be devoted to the latest advancements in green chemistry principles applied to these areas of drug discovery. We will explore topics like utilizing alternative solvents such as deep eutectic solvents (DESs), and solvent-free methods like mechanochemistry, minimizing waste generation, and employing biocatalysis for efficient and sustainable syntheses.

This event provides an excellent opportunity to explore the application of green chemistry principles in pharmaceutical development.

Date: 5 September 2024 at 3:00 p.m. CEST | 9:00 a.m. EDT | 9:00 p.m. CST Asia
Webinar ID: 893 7557 6954

Register now for free!

Program

Speaker

Presentation Title

Time in CEST

Time in EDT

Time in CST Asia

Dr. Mafalda Cruz Sarraguca & Dr. Clara Gomes

Chair Introduction

3:00–3:10 p.m.

9:00–9:10 a.m.

9:00–9:10 p.m.

Prof. Senka Vidovic

The Future of Natural Resource Utilization and Its Current Barriers

3:10–3:30 pm

9:10–9:30 am

9:10–9:30 pm

Assoc. Prof. Marina Cvjetko Bubalo

Enhancing enzyme stability in deep eutectic solvents: Innovative approaches to biocatalysis

3:30–3:50 p.m.

9:30–9:50 a.m.

9:30–9:50 p.m.

Dr. Vânia André

Innovating Antibiotics with Mechanochemistry

3:50–4:10 p.m.

9:50–10:10 a.m.

9:50–10:10 p.m.

 

Q&A Session

4:10–4:25 p.m.

10:10–10:25 a.m.

10:10–10:25 p.m.

Dr. Mafalda Cruz Sarraguca & Dr. Clara Gomes

Closing of Webinar

4:25–4:30 pm

10:25–10:30 am

10:25–10:30 pm

After registering, you will receive a confirmation email containing information on how to join the webinar. Registrations with academic institutional email addresses will be prioritized.

Unable to attend? Register anyway and we’ll let you know when the recording is available to watch!

Webinar Chairs and Keynote Speakers:

  • Dr. Mafalda Cruz Sarraguca, LAQV-REQUIMTE, Departamento de Ciências Químicas, Faculdade de Farmácia, Universidade do Porto, Rua Jorge Viterbo Ferreira, 228, 4050-313 Porto, Portugal;
  • Dr. Clara Gomes, LAQV-REQUIMTE, Departamento de Química, Faculdade Ciências e Tecnologia, Universidade NOVA de Lisboa, Campus de Caparica, 2829-516 Caparica, Portugal;
  • Prof. Senka Vidovic, Faculty of Technology Novi Sad, University of Novi Sad, Department of pharmaceutical engineering, Serbia;
  • Assoc. Prof. Marina Cvjetko Bubalo, University of Zagreb Faculty of Food Technology and Biotechnology, Croatia;
  • Dr. Vânia André, Centro de Química Estrutural, Institute of Molecular Sciences, Instituto Superior Técnico, Universidade de Lisboa; IST-ID, Portugal.

Relevant Special Issue

20th Anniversary of Pharmaceuticals—Green Techniques for Organic and Organometallic/Coordination Synthesis and Medicinal Chemistry"
Edited by Dr. Mafalda Cruz Sarraguca and Dr. Clara Gomes
Deadline for manuscript submissions: 27 September 2024

For more information, please see the following website: https://sciforum.net/event/Pharmaceuticals-3.

7 August 2024
MDPI Insights: The CEO's Letter #14 - New Headquarters, Marketing, Poland

Welcome to the MDPI Insights: The CEO's Letter.

In these monthly letters, I will showcase two key aspects of our work at MDPI: our commitment to empowering researchers and our determination to facilitating open scientific exchange.


Opening Thoughts

MDPI Moves to New Headquarters in Basel, Switzerland

I am excited to share that MDPI has moved to a new state-of-the-art office space in Basel, Switzerland. This move consolidates our operations by bringing together our two previously separated Basel offices into one central location.

We are always growing our talent pool and encourage you to view our Careers Page for the positions available in Basel and across our offices.

New Address: Grosspeteranlage 5, CH-4052 Basel, Switzerland

Effective Date: 1 July 2024

This new chapter in our company’s journey is designed to continue our mission of positioning MDPI as a leader in Open Access (OA) publishing, highlighting our commitment to making scholarly research accessible to everyone.

Boasting modern amenities, improved meeting and event spaces designed to support our growing needs, the new location provides a more collaborative and efficient working environment for our employees. The location offers convenient accessibility to public transportation and is situated near the Basel SBB railway station, with a variety of nearby services and amenities.

In fact, I can see the trains right outside of my window as I write these lines!

This move marks an exciting milestone in MDPI’s development, and I am confident that the new headquarters will serve as an inspiring and productive space for everyone. We also very much look forward to welcoming visitors here. You can read more about MDPI's history here.

“This new chapter continues our mission of positioning MDPI as a leader in OA publishing”

For Those New to MDPI

A pioneer in scholarly, Open Access publishing, MDPI has supported academic communities since 1996. MDPI is leading the transition to Open Science by making a greater proportion of the research conducted worldwide free and accessible to everyone. To date, over 3.5 million researchers have entrusted MDPI with publishing their scientific discoveries. MDPI’s editorial process is bolstered by a network of dedicated reviewers, a team of 6,000 professional, well-trained staff members, and an in-house article submission platform designed to ensure efficient processes within its 440 fully Open Access titles. MDPI supports more than 800 academic institutions worldwide, helping them adhere to national mandates while facilitating authors’ publication in fully compliant (CC BY) Open Access journals.

Impactful Research

New and Emerging MDPI Journals Making an Immediate Impact

Unpacking some of the Impact Factor updates from the June CEO Letter, I wanted to dive a little deeper into the 137 MDPI journals which received Impact Factor for the first time.

Academic authors highly value efficient publishing processes, robust editorial support, and the opportunity to publish in high-impact journals. We are proud that our newly launched journals typically achieve coverage in the Emerging Sources Citation Index (ESCI) of the Web of Science within just a few years, with a median time of only three years from release to inclusion.

As part of our commitment to advancing academic research and providing high-quality OA publishing, we actively seek new research areas to expand our portfolio of journals. We have a proven track record of successfully establishing new journals.

Our dedicated teams excel in fostering dynamic editorial boards and working closely with Editors-in-Chief (EiC) to define the precise scope and focus of each new journal. Our expertise extends to collaborating with indexing services, ensuring that our journals comply with best practices and are indexed promptly in all relevant databases.

Emerging Titles Ranked for the First Time

Our commitment to excellence is reflected in the annual impact metrics released this past June. The latest edition of the Journal Citation Reports (JCR) showcases the integration of journals from the ESCI in the new unified category rankings, providing a simplified and more complete view of all journals within each subject category, including newly established titles.

Out of 137 new and developing MDPI journals ranked in the 2024 release, 79 are in the top half (Q1 or Q2) of their categories. Here is a breakdown of the number of MDPI’s ESCI-indexed journals by quartile in the JCR:

Quartile No. of journals
Q1 17 (12.4%)
Q2 62 (45.3%)
Q3 43 (31.4%)
Q4 15 (10.9%)
Not ranked (humanities-related journals) 2

These rankings highlight our success in rapidly establishing high-impact new journals. Among those that made it directly into the top 25% of their category are the International Journal of Neonatal Screening, Journal of Xenobiotics, Polysaccharides, Smart Cities, and thirteen other journals.

You can browse MDPI journals by Indexing. Simply visit our Journals page and select from the list of Indexing bodies in the top left-hand corner.

For quick reference, as at 31 July 2024:

Inside MDPI

MDPI Corporate Marketing Strategy and Team Meeting 2024

In July, I hosted the annual Corporate Marketing strategy and team-building activity with 15 of our team members.

The aim was to align the Corporate Marketing strategy with MDPI's goal of becoming the world's most trusted OA publisher. While we provide a high-level publishing experience for our authors, as seen from our surveys, we need to keep building on our transparent and open communication to foster trust within the scholarly community and continue enhancing our reputation.

The Corporate Marketing team plays an important role as the mouthpiece for all our major activities within MDPI, especially those that model what it means to be a trusted partner. The purpose of the strategy meeting was to develop a feeling of trust in one another and an understanding of how to inspire trust in the stakeholders with whom we interact.

“We need to keep building on our transparent and open communication to foster trust within the scholarly community”

We conducted a set of activities to facilitate that sense of mutual trust and trustworthiness. Examples of some activities we worked on during this strategy-building event include:

  • Exploring what trust means
    • ‘Letter to self’
    • ‘The brand I most trust’
  • Most Trusted Academic Publisher
    • ‘The brand I would like MDPI to become’
    • ‘The 2029 MDPI Annual Report’
    • Voice of Customer and Share of Voice – survey/data update on MDPI Brand Experience and Brand Perception
  • Integrate Trust-Based Objective into Marketing Plan
    • ‘Becoming the MDPI experience’
    • ‘Trusting the next steps’

While two days is not enough to finalize a marketing strategy, it is sufficient to get everyone who attended into the mindset of the direction in which we are working. From here, we will develop a program with next steps on main projects, update communications, and collaborate with team leads to incorporate this approach into our work going forward.

As a marketing team, we can communicate our messages, but trust has to be built at every touchpoint in the stakeholder journey. Just talking about it isn’t enough. We need to be about it. That’s a role each of us plays, from editorial to IT, from marketing to HR. We must build trust from the inside out. It starts with each manager and resonates out via every team member.

As a company, our goal is to give all stakeholders with whom we interact – whether internal or external – the experience of working with an organization it can trust.

Coming Together for Science

MDPI in Poland: Krakow Office

In July, I had the pleasure of visiting our Krakow office, following my recent trip to Warsaw to meet with the Polish Ministry of Science and Higher Education.

During these visits, I prioritized meeting with our Office Manager, Editorial Director, Group Leads, and members from various teams, including editorial, production, marketing, and journal relationship specialists, to understand their roles and current challenges. Instead of a formal presentation, I opted for an open discussion, sharing updates from headquarters to engage with colleagues in a more personal way.

Our Krakow office has many things to be proud of, including a large number of PhD colleagues (over a third of its staff holds a PhD degree). Krakow provides an opportunity for expanding beyond the 100 colleagues we currently have, by adding new hires in departments including editorial, production and marketing, among others.

About our Krakow office

  • Opened in 2020
  • 99 staff members as at 1 August 2024
  • Main Departments include Editorial, Production, English Department, JRS, PR

Our Krakow office participates in international conferences, conducts author trainings and scholar visits, and engages in local market outreach. The office is also a member of the Polish Chamber of Commerce for High Technology (IZTECH) and is working on expanding its local engagement.

Krakow is the second-largest city in Poland, with a population of about 800,000. It also has a large student population of around 128,000, with seven universities. This means that roughly one in every eight residents is a student.

Poland and MDPI

Poland is a crucial market for MDPI. From 2020 to June 2024, Poland ranked 7th in submissions and 5th in publications for MDPI research articles. As at 31 July 2024, Poland ranks 7th in total MDPI publications, with approximately 70,000 research papers.

Between 2020 and June 2024, 61,500 authors from Poland published with MDPI. As at 30 June 2024, there are 1,205 active Editorial Board Members (EBMs) from Poland, with 661 EBMs (55% of the total) having an H-index over 25.

We also have four Editors-in-Chief (EiC) from Poland leading our journals: Coatings, Venereology, Advances in Respiratory Medicine, and Limnological Review, along with six Section EiC.

In 2023, we received approximately 21,000 submissions from Polish-affiliated authors, of which 12,032 were published.

“Poland is a crucial market for MDPI”

Meeting with Ministry of Education

On 22 July, we visited Warsaw to meet with the Polish Ministry of Science and Higher Education.

We were pleased to learn that they are strong supporters of the OA publishing model and value MDPI’s approach to the peer-review process, including our high ethical standards for quality control.

In 2023 Polish authors predominantly published their papers in OA, with MDPI holding the largest market share in OA publications within the country.

Our commitment to collaborating with Polish institutions is evident through our 33 Institutional Open Access Program (IOAP) agreements with prestigious institutions such as the University of Warsaw, the University of Wroclaw, the Jagiellonian University, and Gdańsk University of Technology. Through IOAP discounts, a healthy waiver rate, and our peer-review voucher system, we provide the Polish scholarly community with significant savings in OA publishing. The Minister greatly appreciated these efforts and our commitment to offsetting some of the APC costs.

We discussed industry concerns about the threat of papermills and presented the preventive measures MDPI has in place to mitigate this risk and uphold high ethical standards. We informed them of our commitment to combating papermills, including our involvement with United2Act and the STM Research Integrity Hub, as well as our efforts to expand our research integrity team and explore proactive measures.

Closing Thoughts

MDPI Thought Leadership Op-ed on Open Access is Now Live on Politico

I am pleased to share that our thought leadership Op-ed piece on Open Access (OA) is now live on Politico. This is a nice push for continued influence and support of OA among policymakers and industry leaders.

Why Politico?

Politico's reputation as a highly credible and influential news platform makes it an important venue to reach key opinion leaders (KOL) from academia, policymakers, and thought leaders from many industries. This visibility helps promote the OA philosophy.

Open Access: A Moral Imperative for Progress

In this piece, I discuss the necessity of making scientific research freely available to all. I argue that publicly funded research should be publicly accessible, highlighting how OA democratizes scientific knowledge, accelerates research availability, and fosters collaboration.

“Open Access is a fundamental right for all citizens”

Democratizing scientific communication
The impulse to democratize scientific communication is nothing new. OA may seem like a recent innovation, but its principles have historical roots traceable to Europe in the 15th century. Just as the printing revolution accelerated the dissemination of new ideas, OA publishing unlocks new scientific insights that would otherwise only be accessible to a few.

Benefits for scholars: amplifying impact through Open Access
Authors publishing in an OA journal can expect more citations of their work, increasing its potential impact. Research findings that are freely available are more likely to be cited than those hidden behind a paywall. Freedom of access greatly increases the potential audience for each paper, fostering a sense of community among researchers worldwide. Heightened visibility can attract prospective collaborators and employers for young scientists. At MDPI, we believe that all these factors can only accelerate the advance of science. Additionally, authors retain copyright in their work instead of signing it away, permitting broader dissemination under Creative Commons licenses and increasing its capacity for impact.

The moral imperative
OA is not just a matter of scientific policy; it is a fundamental right for all citizens and a prerequisite for a brighter, more informed future. Publicly funded research should be a top priority, and I am pleased to see policy moving in this direction. Our capacity to generate transformative scientific insights has to be democratized. The question today is no longer whether we can afford to embrace OA; rather, it is whether we can afford not to.

Stefan Tochev
Chief Executive Officer
MDPI AG

6 August 2024
Pharmaceuticals | 20th Anniversary


This year marks the 20th anniversary of Pharmaceuticals (ISSN: 1424-8247, CiteScore: 6.1), an international scientific journal of medicinal chemistry and related drug sciences that is published monthly online by MDPI. It covers medicinal chemistry, biopharmaceuticals, natural products, radiopharmaceutical sciences, pharmacology and pharmaceutical technology.

Since the establishment of Pharmaceuticals in 2004, the journal has published over 6000 papers, including more than 2365 that have been cited at least 10 times. During the past 20 years, Pharmaceuticals has significantly contributed to scientific advancements in the field of drug sciences.

We would like to express our sincerest gratitude to our readers, innumerable authors, anonymous peer reviewers, editors, and everyone working in some way for the journal, for your outstanding work in fostering the vision and supporting the mission of our journal. Without your support, we would never have achieved this significant milestone.

To celebrate the 20th anniversary of Pharmaceuticals, we are arranging events and the release of special content. We hope that you will be able to join us for this celebration. For more information about our anniversary events, please visit: https://www.mdpi.com/journal/pharmaceuticals/anniversary.

If you have any questions, suggestions, or recommendations, please do not hesitate to contact pharmaceuticals@mdpi.com.

Pharmaceuticals Editorial Office

Back to TopTop